Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell
S Modvig1, H O Madsen1, S M Siitonen2
1Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Leukemia
|December 12, 2019
Abstract:
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.3K
06:41Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
Published on: July 19, 2024
1.3K
